| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $319.0M | +3.4% |
| Cost of Revenue | $75.5M | +3.3% |
| Gross Profit | $243.5M | +3.4% |
| R&D Expense | $85.0M | -10.6% |
| SG&A Expense | $49.4M | -11.8% |
| Operating Income | -$54.9M | +38.2% |
| Pre-tax Income | -$74.3M | +28.8% |
| Income Tax | $1.3M | +6.6% |
| Net Income | -$75.6M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.9M | -8.4% |
| Accounts Receivable | $67.2M | -14.9% |
| Current Assets | $153.7M | -8.9% |
| Total Assets | $225.7M | -6.8% |
| Current Liabilities | $237.8M | -4.3% |
| Long-term Debt | $113.5M | +4.5% |
| Total Liabilities | $379.2M | -2.4% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.6M | +123.7% |
| Capital Expenditures | $11.7M | +46.7% |
| Investing Cash Flow | -$11.8M | -47.1% |
| Financing Cash Flow | $3.5M | +43.2% |
| Free Cash Flow | -$9.2M | +51.5% |
| +28.4% |
| EPS (Basic) | -$2.10 | +32.3% |
| EPS (Diluted) | -$2.10 | +32.3% |
| Stockholders' Equity |
| -$153.5M |
| -4.9% |